Impact of chronic atrial fibrillation on cardiovascular mortality;Impatto della fibrillazione atriale cronica sulla mortalita cardiovascolare

Italian Heart Journal Supplement

Volumn 1, Issue 9, 2000, Pages 1117-1122

  Scardi, S ^a   Mazzone, C ^a  

^a Centro Cardiovascolare   (Italy)

Author keywords

Atrial fibrillation; Epidemiology; Mortality; Stroke

Indexed keywords

ANTIARRHYTHMIC AGENT; WARFARIN;

AGE; ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; MORTALITY; PROGNOSIS; REVIEW; SINUS RHYTHM; SMOKING; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; DEATH, SUDDEN; HUMANS; RISK FACTORS;

EID: 0033744982     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
2. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study
3. Atrial fibrillation and stroke. Three new studies, three remaining questions
4. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
5. Atrial fibrillation (clinical manifestations)
6. Atrial fibrillation in elderly ambulatory patients
7. Mortality in an insured population with atrial fibrillation
8. Atrial fibrillation. Etiology, course and prognosis. A follow-up study of 1212 cases
9. Epidemiological features of chronic atrial fibrillation. The Framingham study
10. Atrial fibrillation and mortality in an elderly population
11. Decrease in mortality in patients with a hospital diagnosis of atrial fibrillation in Denmark during the period 1980-1993
12. Exercise capacity and prognosis in patients with chronic atrial fibrillation
13. The natural history of atrial fibrillation: Incidence, risk factors and prognosis in the Manitoba follow-up study
14. Increased mortality, stroke and medical costs imposed by atrial fibrillation
15. Characterization of different subsets of atrial fibrillation in general practice in France: Tha ALFA study. The College of French Cardiologists
16. Mortality and cause of death in patients with chronic nonrheumatic atrial fibrillation after two year follow-up
17. Risk of stroke in nonrheumatic atrial fibrillation
18. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris prospective study I
19. The natural history of lone atrial fibrillation. A population-based study over three decades
20. Lone atrial fibrillation: Prognostic differences between paroxysmal and chronic forms after 10 years of follow-up
21. Chronic atrial fibrillation - Epidemiologic features and 14 year follow-up. A case control study
22. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS registry)
23. Prognostic significance of atrial fibrillation in advanced heart failure
24. Atrial fibrillation in mild to moderate heart failure is independently associated with progressive pump failure death
25. Predictors of sudden death in idiopathic cardiomyopathy
26. Factors influencing the one-year mortality of dilated cardiomyopathy
27. Mode of death in idiopathic dilated cardiomyopathy: A multivariate analysis of prognostic determinants
28. Improving survival for patients with atrial fibrillation and advanced heart failure
29. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators
30. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study
31. Early recurrent embolism associated with non valvular atrial fibrillation, a retrospective study
32. Duration of atrial fibrillation and imminence of stroke: The Framingham study
33. TASAF: Trieste Area Study on Non Rheumatic Atrial Fibrillation. The results of the enrolled study population
34. D-dimer and anticoagulation in patients with mechanical prosthetic heart valves
35. Atrial fibrillation follow-up investigation of rhythm management. The AFFIRM study design
36. Pilot study and protocol of the Canadian Trial at Atrial Fibrillation (CTAF)
37. Atrial fibrillation: Maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: The PIAF trial